文献速递白血病

C1Q标记高侵袭性巨噬细胞样白血病细胞群,提示髓外浸润与复发

C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse.
PubMed 文献 · Blood · 2023-01-01

该研究对一例伴泛发性皮肤白血病表现的急性髓系白血病(AML)患者的骨髓与髓外浸润(EMI)样本行单细胞RNA测序,鉴定出补体C1Q+巨噬细胞样白血病亚群,该亚群在皮肤浸润灶富集且EMI表现前已存在于骨髓,并在多名AML患者中验证。基因组与转录谱分析显示C1Q高表达患者具有特定突变与基因表达特征,C1Q表达受转录因子MAF BZIP转录因子B调控,赋予白血病细胞组织浸润能力,并在患者来源异种移植与细胞系来源异种移植模型中形成显著皮肤或胃肠道EMI结节。成纤维细胞通过C1Q-球状C1Q受体识别及后续转化生长因子β1刺激吸引C1Q+白血病细胞迁移,该细胞间通讯也促进C1Q+白血病细胞在化疗应激下存活。单变量与多变量分析显示C1Q表达不良预后意义,C1Q为不良预后AML标志物并通过与成纤维细胞通讯协调癌症浸润通路,为EMI的 compelling 治疗靶点。

要点

  • C1Q+巨噬细胞样白血病亚群在皮肤浸润灶富集,且在EMI表现前已存在于骨髓。
  • C1Q表达受MAF BZIP转录因子B调控,赋予白血病细胞组织浸润能力。
  • 成纤维细胞经C1Q-球状C1Q受体识别及TGF-β1刺激吸引C1Q+白血病细胞并促其化疗应激下存活。

核心结论

  • C1Q作为不良预后AML的标志物,通过与成纤维细胞通讯协调癌症浸润通路,并代表EMI的 compelling 治疗靶点。

研究设计与样本

  • 对一例伴泛发性皮肤白血病表现的AML患者的骨髓与EMI样本行单细胞RNA测序,并在多名AML患者中验证。
  • 采用基因组与转录谱分析、RNA测序与定量蛋白质组学分析,以及患者来源异种移植和细胞系来源异种移植模型。

主要发现

  • 鉴定出补体C1Q+巨噬细胞样白血病亚群,在皮肤浸润灶富集且EMI表现前已存在于骨髓,并在多名AML患者中验证。
  • 基因组与转录谱分析揭示表达高水平C1Q的EMI患者的突变与基因表达特征。
  • RNA测序与定量蛋白质组学分析揭示C1Q从原发到复发的表达动态。
  • 单变量与多变量分析证明C1Q表达的不良预后意义。
  • C1Q表达受转录因子MAF BZIP转录因子B调控,赋予白血病细胞组织浸润能力,在患者来源异种移植与细胞系来源异种移植模型中可形成显著皮肤或胃肠道EMI结节。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Extramedullary infiltration (EMI) is a concomitant manifestation that may indicate poor outcome of acute myeloid leukemia (AML). The underlying mechanism remains poorly understood and therapeutic options are limited. Here, we employed single-cell RNA sequencing on bone marrow (BM) and EMI samples from a patient with AML presenting pervasive leukemia cutis. A complement C1Q+ macrophage-like leukemia subset, which was enriched within cutis and existed in BM before EMI manifestations, was identified and further verified in multiple patients with AML. Genomic and transcriptional profiling disclosed mutation and gene expression signatures of patients with EMI that expressed high levels of C1Q. RNA sequencing and quantitative proteomic analysis revealed expression dynamics of C1Q from primary to relapse. Univariate and multivariate analysis demonstrated adverse prognosis significance of C1Q expression. Mechanistically, C1Q expression, which was modulated by transcription factor MAF BZIP transcription factor B, endowed leukemia cells with tissue infiltration ability, which could establish prominent cutaneous or gastrointestinal EMI nodules in patient-derived xenograft and cell line-derived xenograft models. Fibroblasts attracted migration of the C1Q+ leukemia cells through C1Q-globular C1Q receptor recognition and subsequent stimulation of transforming growth factor β1. This cell-to-cell communication also contributed to survival of C1Q+ leukemia cells under chemotherapy stress. Thus, C1Q served as a marker for AML with adverse prognosis, orchestrating cancer infiltration pathways through communicating with fibroblasts and represents a compelling therapeutic target for EMI.

来源:Blood,查看原文。版权归原作者所有。

引用

  1. Yang LX, Zhang CT, Yang MY, et al. C1Q labels a highly aggressive macrophage-like leukemia population indicating extramedullary infiltration and relapse. Blood. 2023. PMID: 36322939. doi:10.1182/blood.2022017046

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。